Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $21.6600 (-1.32%) ($21.4600 - $21.6600) on Fri. Dec. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.3% (three month average) | RSI | 46 | Latest Price | $21.6600(-1.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.15% in a week (0% probabilities). VIXM(-34%) VXX(-26%) UNG(-10%) UUP(-8%) TLT(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.15% (StdDev 4.3%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $23.51 | 5 Day Moving Average | $22.51(-3.78%) | 10 Day Moving Average | $23.5(-7.83%) | 20 Day Moving Average | $23.51(-7.87%) | To recent high | -17.7% | To recent low | 72.6% | Market Cap | $1.61b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |